{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:10:48Z","timestamp":1787163048395,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T00:00:00Z","timestamp":1728777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006571","name":"Canterbury District Health Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001537","name":"University of Auckland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.pan.2024.10.008","type":"journal-article","created":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T11:38:38Z","timestamp":1728819518000},"page":"1288-1293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prescribing of pancreatic enzyme therapy for malabsorption in unresectable pancreatic cancer: Cross-sectional survey across New Zealand and Australia"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7385-3739","authenticated-orcid":false,"given":"Amanda","family":"Landers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh","family":"Fanning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera R.","family":"Agar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7112-0785","authenticated-orcid":false,"given":"Vanessa M.","family":"Yenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0978-4798","authenticated-orcid":false,"given":"Kate","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5995-5432","authenticated-orcid":false,"given":"John","family":"Windsor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pan.2024.10.008_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12957-021-02478-x","article-title":"Prognosis and survival analysis of patients with pancreatic cancer: retrospective experience of a single institution","volume":"20","author":"Li","year":"2022","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.pan.2024.10.008_bib2","series-title":"Pancreatic cancer quality improvement monitoring report","year":"2023"},{"issue":"12","key":"10.1016\/j.pan.2024.10.008_bib3","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.dld.2015.06.015","article-title":"Pancreatic exocrine insufficiency in pancreatic cancer: a review of the literature","volume":"47","author":"Bartel","year":"2015","journal-title":"Dig Liver Dis"},{"issue":"5","key":"10.1016\/j.pan.2024.10.008_bib4","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1097\/MCG.0b013e31829f56e7","article-title":"A\u00a0prospective assessment of the natural course of the exocrine pancreatic function in patients with a pancreatic head tumor","volume":"48","author":"Sikkens","year":"2014","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.pan.2024.10.008_bib5","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s10620-017-4524-z","article-title":"Potential for screening for pancreatic exocrine insufficiency using the fecal elastase-1 test","volume":"62","author":"Dom\u00ednguez-Mu\u00f1oz","year":"2017","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.pan.2024.10.008_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bmjspcare-2014-000694","article-title":"Pancreatic enzyme replacement therapy (PERT) for malabsorption in patients with metastatic pancreatic cancer","volume":"6","author":"Landers","year":"2016","journal-title":"BMJ support"},{"issue":"1","key":"10.1016\/j.pan.2024.10.008_bib7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/bjc.1997.17","article-title":"Changes in nutritional status associated with unresectable pancreatic cancer","volume":"75","author":"Wigmore","year":"1997","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.pan.2024.10.008_bib8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/nu9030243","article-title":"Nutritional and metabolic derangements in pancreatic cancer and pancreatic resection","volume":"9","author":"Gilliland","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.pan.2024.10.008_bib9","series-title":"BMJ support","article-title":"Enzyme replacement in advanced pancreatic cancer: patient perceptions","author":"Landers","year":"2020"},{"key":"10.1016\/j.pan.2024.10.008_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.688889","article-title":"Pancreatic enzyme replacement therapy in patients undergoing first-line gemcitabine plus nab-paclitaxel for advanced pancreatic adenocarcinoma","volume":"11","author":"Trestini","year":"2021","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.pan.2024.10.008_bib11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pan.2018.10.010","article-title":"Enzyme replacement improves survival among patients with pancreatic cancer: results of a population based study","volume":"19","author":"Roberts","year":"2019","journal-title":"Pancreatology"},{"issue":"2","key":"10.1016\/j.pan.2024.10.008_bib12","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.pan.2015.12.006","article-title":"Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency","volume":"16","author":"Smith","year":"2016","journal-title":"Pancreatology"},{"key":"10.1016\/j.pan.2024.10.008_bib13","article-title":"Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelines","volume":"8","author":"Phillips","year":"2021","journal-title":"BMJ Open Gast"},{"key":"10.1016\/j.pan.2024.10.008_bib14","first-page":"1097","article-title":"Real-world patient experience with pancreatic enzyme replacement therapy in the treatment of exocrine pancreatic insufficiency","volume":"10","author":"Barkin","year":"2023","journal-title":"Pancreas"},{"issue":"6","key":"10.1016\/j.pan.2024.10.008_bib15","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/MPA.0000000000001330","article-title":"Frequency of appropriate use of pancreatic enzyme replacement therapy and symptomatic response in pancreatic cancer patients","volume":"48","author":"Barkin","year":"2019","journal-title":"Pancreas"},{"issue":"4","key":"10.1016\/j.pan.2024.10.008_bib16","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.amjmed.2005.12.021","article-title":"Approaches to patient education: emphasizing the long-term value of compliance and persistence","volume":"119","author":"Gold","year":"2006","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.pan.2024.10.008_bib17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12875-022-01641-x","article-title":"Sustainability of healthcare professionals' adherence to clinical practice guidelines in primary care","volume":"23","author":"Liu","year":"2022","journal-title":"BMC Primary Care"},{"issue":"11","key":"10.1016\/j.pan.2024.10.008_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-076242","article-title":"Recruitment of participants with pancreatic cancer to a mixed media study for optimal recruitment in an Australasian survey of pancreatic enzyme replacement","volume":"13","author":"Landers","year":"2023","journal-title":"BMJ Open"},{"issue":"10","key":"10.1016\/j.pan.2024.10.008_bib19","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/apt.15698","article-title":"The use of pancreatic enzyme replacement therapy in patients with a diagnosis of chronic pancreatitis and pancreatic cancer in the US is infrequent and inconsistent","volume":"51","author":"Forsmark","year":"2020","journal-title":"Aliment Pharmacol Therapeut"},{"key":"10.1016\/j.pan.2024.10.008_bib20","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s11605-012-1927-1","article-title":"The daily practice of pancreatic enzyme replacement therapy after pancreatic surgery: a northern European survey: enzyme replacement after surgery","volume":"16","author":"Sikkens","year":"2012","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"10","key":"10.1016\/j.pan.2024.10.008_bib21","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.hpb.2022.05.003","article-title":"Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States","volume":"24","author":"Jain","year":"2022","journal-title":"HPB"},{"issue":"6","key":"10.1016\/j.pan.2024.10.008_bib22","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.pan.2021.05.299","article-title":"Pancreatic enzyme replacement therapy in patients with pancreatic cancer: a national prospective study","volume":"21","author":"Harvey","year":"2021","journal-title":"Pancreatology"},{"issue":"11","key":"10.1016\/j.pan.2024.10.008_bib23","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.dld.2012.05.017","article-title":"Faecal elastase-1 is an independent predictor of survival in advanced pancreatic cancer","volume":"44","author":"Partelli","year":"2012","journal-title":"Dig Liver Dis"},{"issue":"7","key":"10.1016\/j.pan.2024.10.008_bib24","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.ejso.2021.03.227","article-title":"The prevalence of micronutrient deficiency in patients with suspected pancreatico-biliary malignancy: results from a specialist Hepato-Biliary and Pancreatic unit","volume":"47","author":"Murphy","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.pan.2024.10.008_bib25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.pan.2015.07.001","article-title":"Clinical, anthropometric and laboratory nutritional markers of pancreatic exocrine insufficiency: prevalence and diagnostic use","volume":"15","author":"Lindkvist","year":"2015","journal-title":"Pancreatology"},{"issue":"1","key":"10.1016\/j.pan.2024.10.008_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100386","article-title":"Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer","volume":"7","author":"Roeyen","year":"2022","journal-title":"ESMO open"},{"key":"10.1016\/j.pan.2024.10.008_bib27","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s12094-020-02350-6","article-title":"Multidisciplinary consensus statement on the clinical management of patients with pancreatic cancer","volume":"22","author":"Martin-Perez","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.pan.2024.10.008_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-5908-4-54","article-title":"Why don't physicians adhere to guideline recommendations in practice? An analysis of barriers among Dutch general practitioners","volume":"4","author":"Lugtenberg","year":"2009","journal-title":"Implement Sci"},{"issue":"11","key":"10.1016\/j.pan.2024.10.008_bib29","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1001\/archpedi.156.11.1086","article-title":"Use of a large national database for comparative evaluation of the effect of a bronchiolitis\/viral pneumonia clinical care guideline on patient outcome and resource utilization","volume":"156","author":"Todd","year":"2002","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"2","key":"10.1016\/j.pan.2024.10.008_bib30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/1747-0080.12613","article-title":"Practice and perspectives of Australian dietitians in management of patients on pancreatic enzyme replacement therapy","volume":"78","author":"Delaney","year":"2021","journal-title":"Nutr Diet"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390324007580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390324007580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T12:56:14Z","timestamp":1733748974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390324007580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1424390324007580"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2024.10.008","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prescribing of pancreatic enzyme therapy for malabsorption in unresectable pancreatic cancer: Cross-sectional survey across New Zealand and Australia","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2024.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of IAP and EPC.","name":"copyright","label":"Copyright"}]}}